Pharmatalkradio

Modernizing Clinical Trials with IQVIA's Dr Cynthia Verst Host: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm:Disrupting Clinical Trials Guest: Dr Cynthia Verst, President, Design and Delivery Innovation for the Research & Development Solutions organization at IQVIA

In this podcast, Valerie Bowling, Executive Director of the Conference Forum, interviews Dr Laura Esserman, breast cancer surgeon and researcher at the University of California, San Francisco. Dr Esserman shares her thoughts on how we can move towards uniting care and clinical research and the future of how medicine should be practiced.

This discussion was presented at the inaugural Drug Delivery West conference in 2018. One of the key challenges in global health is ensuring safe and effective delivery of life saving interventions to remote and non-clinical settings. The Bill & Melinda Gates Foundation invests in technologies, which will help achieve this goal. Learn about an RFP they are launching to indentify new ideas for delivering lyophilized products and how you can participate. Presented by David Robinson, PhD, Deputy Director, The Bill & Melinda Gates Foundation   To learn more about the 2019 Drug Delivery West conference taking place May 6-7, 2019 in San Francisco, CA, please click here.

This panel, presented at the inaugural Drug Delivery West conference in 2018, provides patient perspectives on what they want from drug delivery technologies. These case examples provide insight that every technology can benefit from and lessons learned through our patient representatives. Co-Moderators: Valerie Bowling, Patient Advocate and Executive Director, Drug Delivery West Sudeshna Dutta Ray, Senior Engineer, Advanced Device Technology and Innovation, Amgen Panelists: Cynthia Goldstein, Patient & Communications Specialist Mikaela Saugstad, Patient, Co-Founder, Director of Customer Relations & Marketing, Gigil Precision LLC Lily Stairs, Patient and Head of Patient Advocacy, Clara Health   To learn more about the 2019 Drug Delivery West conference taking place May 6-7, 2019 in San Francisco, CA, please click here.

In this discussion, CRAACO co-chair, Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc, and Alison Bateman-House, PhD, MPH, MA, Assistant Professor Division of Medical Ethics, NYU Langone Health, consider what lines are being drawn in the integration of clinical care and clinical research. More specifically: Research and care or treatment are separate spheres in the regulatory and ethical worlds. What happens when they are brought together?Are there ethical barriers that need to be overcome to allow clinical research to be offered as an option as part of clinical care?What are the ethical issues that surround offering a patient the opportunity to consider enrolling in a clinical trial?What current efforts are underway to address these issues? This session was presented at the Clinical Research as a Care Option (CRAACO) meeting in April 2018 in Cambridge, MA. The 2019 CRAACO conference will take place April 29-30, 2019 in Raleigh-Durham, NA. Learn more here.

In this discussion, stakeholders from medical practices, hospitals, service providers, and patient advocacy discuss how medical practices can offer clinical trials to patients. Including: Infrastructure and supportHow to establish physician championsHow to influence leadership supportContacting patients Moderated by: Jennifer Byrne, Founder, Greater Gift Initative Panelists: Judy Hung, MD, Director Trial Innovation Unit, Division of Clinical Research, Massachusetts General Hospital Jeff James, CEO, Wilmington Health Greg Sweatt, Senior EVP Value Based Crae, Co-Founder, ePatient Finder Kurt Waldhuetter, VP Research Innovation & Business, Aurora Research Institute   This panel was presented at the Clinical Research as a Care Option (CRAACO) meeting on April 11, 2018 in Cambridge, MA. The 2019 CRAACO conference will take place April 29-30, 2019 in Raleigh-Durham, NC. Find out more here.

Murray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes: What are the blockers or conflicts (laws, culture, behaviors, etc) that prevent clinical research from becoming a care option?What is the difference between a movement and an initiative - how should be think about clinical research as a care option? Benefits?What are the enablers or requirements to incorporate clinical research into care options for the patient?How to pave a path for possibilityUpdate on data to support how trials can be a care option This discussion was held at the Clinical Research as a Care Option (CRAACO) meeting held April 11, 2018 in Cambridge, MA. The 2019 CRAACO meeting will take place April 29-30 in Raleigh-Durham, NC. Find out more here.

Jonathan Jackson, PhD, Director CARE Research Center, Massachusetts General Hospital, and Jim Kremidas, Executive Director, Association of Clinical Research Professionals (ACRP) sit down for a frank discussion on the benefits of offering clinical research in underserved communities. Many communities, whether affected by race, ethnicity, or socioeconomic lines, are underrepresented in clinical research. How can offering these care options enhance access to other resources in a broader sense and better educate these communities to the opportunities that clinical research provides?   This discussion was presented at the Clinical Research as a Care Option (CRAACO) meeting on April 11, 2018 in Cambridge, MA. The 2019 CRAACO conference will take place April 29-30 in Raleigh-Durham, NC. Find out more here.

Chief Medical Officer Summit co-chair, Jim Roach, and prominent biotech investor, Elizabeth Stoner, sit down for a fireside chat to discuss what investors are seeking when investing in a biotech company, particularly traits of a Chief Medical Officer. Stoner shares her insights on longevity, key qualities of an effective CMO, and how her perspective as a biotech veteran and former director of clinical development across biopharma both large and small is affecting her investment decisions in the future of the biotech industry. You can join us at the 7th annual Chief Medical Officer Summit happening April 4-5, 2019 in Boston. To learn more visit theconferenceforum.org

Mark Currie, President of R&D at Ironwood Pharmaceuticals, shares his amazing journey driving a product from establishing the foundation for the discovery of linaclotide by Ironwood scientists and leading every aspect of linaclotide's development and regulatory review. He shares his thought processes, pressure points, and lessons learned in leading the R&D team to get a product successfully to market. For more information on the Chief Medical Officer Summit and details for the 7th annual program taking place April 4-5, 2019 in Boston, please visit theconferenceforum.org

In this podcast, Dr Alison Bateman-House, Assistant Professor, Division of Medical Ethics at NYU Langone Health, discusses the debate of compassionate use and the right to try. It dives into the implications, both positive and negative, of opening up that door.

In this podcast, Raju Joshi, Managing Partner at Clinical Partners Group and Dr Zain Kassam, CSO at Finch Therapeutics, discuss how CMO's can more effectively communicate with CEO's, CSO's, and Clinical Operations executives in order to prove a comprehensive summary of the science and business aspects of the company. You can join us at the 7th annual Chief Medical Officer Summit happening April 4-5, 2019 in Boston. To learn more visit theconferenceforum.org.

Mary Stober Murray, Associate Director, Diversity and Patient Engagement for BMS, discusses applying quality systems framework (structure, processes, outcomes) to patient engagement initiatives to help create clinical development deliverables that meet industry goals while aligning with patients needs. Mary Stober Murry will be joining the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia to lead a roundtable discussion on Building Patient Engagement into Systematic Processes. Patients as Partners US is the only conference that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.  For more information visit www.theconferenceforum.org.   

In this podcast, we were joined by Mr Charles Graeber, award-winning journalist and author who recently published The Breakthrough: Immunotherapy and the Race to Cure Cancer along with Dr James Gulley, Head of the Immunotherapy Section and Director of the Medical Oncology Service at the Center for Cancer Research within the National Cancer Institute. Together Mr Graeber and Dr Gulley delved into the significance of this moment in science, what the progress has been and explore what is next on the horizon within immuno-oncology. Both Dr Gulley and Mr Graeber will be presenting at the 5th annual IO360°, February 6-8 at The Crowne Plaza Times Square Hotel, NYC. For more information visit IO360°.

This podcast features a panel previously recorded at the 5th annual Patients as Partners US program on Engaging Patients By Giving Them their Data. The panel, moderated by David Leventhal, Director of Clinical Innovation for Pfizer, discussed: • What information and data do patients want during a clinical trial? • What initiatives is pharma currently doing to support this? • What impact will it have if patients have access to their data? Additional panelists included: Jenny Ahlstrom, Myeloma survivor and Co-founder, CrowdCare Foundation Kristina Figueroa, MSPH, Patient and Advocate Cindy Geoghegan, Cancer Survivor, Patient Advocate & Team Lead, CTTI’s Mobile Clinical Trials Stakeholder Perceptions Project Thérèse Johnsen, Associate Director, Patient Engagement Management, Novartis Join us for the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia where we feature extended sessions on The Democratization of Patient Dat

Les Jordan, Working Group Member and Cindy Geoghegan, Team Lead for CTTI, the Clinical Trials Transformation Initiative, share findings from a multi-stakeholder project undertaken by the Clinical Trials Transformation Initiative to better understand patient perspectives on mobile technologies in clinical trials. The survey, conducted amongst 100 patients across multiple therapeutic areas, evaluated the ways patients would be willing to use mobile technologies and the impact on their participation in clinical trials. Additional focus areas included: • Potential impacts of mobile on participant experiences in clinical trials • Patient willingness to share personal health data • Important attributes for designing trials that address patient preferences and expectations • Implications for the research enterprise CTTI will also be joining the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia where they will share newly-released re

Dr Marilyn Metcalf, Head of the Center of Innovation for GSK, at the 5th annual Patients as Partners 2018 program. Dr Metcalf shares how GSK implemented pivotal end-to-end engagement initiatives at different stages of development. Dr Metcalf walked the audience through some examples of the engagement initiatives supported by: • Creation of a framework and toolkit that builds on existing infrastructure • Networks of champions and project leads • Project planning • Emerging best practices being shared throughout the organization Dr Metcalf will also be joining the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia where she leads a panel with patients and advocacy on Mapping Out the Patient Decision Making Journey. Patients as Partners US is the only conference that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. For more information vis

To prevent ticking off a box and to ensure that patient involvement is systemic and sustainable, we have to move into patient-centricity 2.0. What does this mean and how is this done so we can turn the patient voice into value, impact, and benefit? This session presented at the 2nd annual Patients as Partners EU meeting, which took place January 2018 in London, demonstrates best practices from Hoffman La Roche, Melanoma Patient Network, Patient Focused Medicines Development, and European Patients Forum. Moderated by: Bettina Ryll, PhD, Founder, Melanoma Patient Network Europe. Panelists: Nicola Bedlington, Secretary General, European Patients ForumNicholas Brooke, Chief Executive Officer, Patient Focused Medicines Development (PFMD)Irmi Gallmeier, Senior International Health Policy Leader, Patient Relations, F. Hoffman La Roche The 3rd annual Patients as Partners EU meeting will take place January 28-29, 2019 in London, UK. Find more information here.

What would have to change to make a patient-centric healthcare system a reality? How can this be achieved, given the huge resistance to change built into current systems? In this session, Alastair Kent, Director of Genetic Alliance UK, addresses: New opportunities to interveneDemographic changeConstrained funding right across EuropeThe introduction of Expert Reference NetworksHow we can work through this collaboratively. This session was presented at the 2nd annual Patients as Partners Europe meeting in London in January 2018. The 3rd Annual Patients as Partners Europe meeting will take place January 28-29, 2019 in London, UK. You can find more information here.

This 8 minute podcast summarizes what you can expect at the 6th annual Patients as Partners US conference. This is the only event that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. The conference takes place March 11-12, 2019 at the Wyndham Philadelphia Historic District, Philadelphia, PA. The program is chaired by Merck's Jan Nissen, VP, Patient Innovation and Engagement, Arthritis Foundation's Suzanne Schrandt, Director of Patient Engagement, and IQVIA's Cynthia Verst, President, Design and Delivery Innovation. For more information please visit www.patientsaspartners.org or contact us at service@tcfllc.org.